https://www.worldpharmatoday.com/research-insight/chugai-pharmaceutical-co-ltd-announced-efficacy-of-actemra-subcutaneous-injection-confirmed-in-dose-interval-reduction-study-in-patients-with-rheumatoid-arthritis/ Magazine for the C-level Pharma Executives Sun, 15 May 2016 18:30:00 +0000 hourly 1 https://wordpress.org/?v=6.9.4